Neurofibromatosis type 1 (NF1) is an inherited neurocutaneous condition that predisposes to the development of peripheral nerve sheath tumors (PNST) including cutaneous neurofibromas (CNF), plexiform neurofibromas (PNF), atypical neurofibromatous neoplasms of uncertain biologic potential (ANNUBP), and malignant peripheral nerve sheath tumors (MPNST). The Johns Hopkins NF1 biospecimen repository promotes the successful advancement of therapeutic developments for NF1-associated PNST through acquisition and genomic analysis of human tumor specimens. RNA sequencing (RNAseq) and whole exome sequencing (WES) data were generated from 73 and 114 primary human tumor samples, respectively. These pre-processed data, standardized for immediate computational analysis, are accessible through the NF Data Portal, allowing immediate interrogation. This dataset combines new and previously released samples, offering a comprehensive view of the entire cohort sequenced. As a dedicated effort to systematically bank tumor samples from people with NF1, in collaboration with molecular geneticists and computational biologists, the Johns Hopkins NF1 biospecimen repository offers access to tissue samples and genomic data to promote the advancement of NF1-related tumor biologic insights and therapies.
Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository dataset.
NF1相关周围神经鞘瘤的综合基因组分析:更新的生物样本库数据集
阅读:4
作者:Banerjee Jineta, Lyu Yang, Makri Stavriani C, Scott Alexandra J, Zhang Lindy, Calizo Ana, Pollard Kai, Yang Kuangying, Gross John M, Lucas Calixto-Hope G, Wang Jiawan, Levin Adam S, Belzberg Allan J, Romo Carlos G, Allaway Robert J, Blakeley Jaishri O, Hirbe Angela C, Pratilas Christine A
| 期刊: | Scientific Data | 影响因子: | 6.900 |
| 时间: | 2025 | 起止号: | 2025 Jul 15; 12(1):1229 |
| doi: | 10.1038/s41597-025-05433-7 | 研究方向: | 神经科学 |
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
